Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Margaret Carpenter, based in New Paltz, New York, has been indicted for prescribing abortion pills to a person in Louisiana — ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
13h
News Medical on MSNScottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
8h
Verywell Health on MSNHow the Female Reproductive System WorksThe female reproductive system includes internal and external organs, each designed to carry out varying functions. Learn more about the anatomy of this system.
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.
Experts say a healthy vaginal microbiome may cut down one's risk of infections like HPV in check. Probiotics can balance pH, ...
8h
Hosted on MSNDublin woman opens up about her experience of cervical screening and how to make it easierBeth Wallace opened up about her cervical screening journey in the hopes that other women will be inspired to attend their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results